Stockreport

2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron

2seventy bio, Inc.  (TSVT) 
PDF - Company Now Exclusively Focused on Development and Commercialization of Abecma - CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), announced tod [Read more]